Bayer HealthCare's Eylea (aflibercept solution for injection into the eye) has been approved by the European Commission for the treatment of visual impairment due to diabetic macular oedema (DMO).

Diabetic macular ... vision loss. The damage occurs when prolonged high blood sugar levels weaken retinal blood vessels, causing them to leak fluid and proteins. This leakage leads to swelling ...